首页 › 基金 › Parkman Healthcare Partners LLC › EWTX

Parkman Healthcare Partners LLC 对 EWTX 的持仓历史

EDGEWISE THERAPEUTICS INC · 医疗保健

Parkman Healthcare Partners LLC 在 Q3 2026 的 13F 申报中披露持有 EWTX(EDGEWISE THERAPEUTICS INC)327,954 股,市值约 US$13.3M,约占其申报组合的 1.20%,在其申报持仓中市值排名第 32 位。 Parkman Healthcare Partners LLC 最近 13 个申报季度中有 13 个季度披露了 EWTX 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)327.95K 股
申报持仓市值$13.31M
组合权重1.20%
首次申报Q3 2023
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Parkman Healthcare Partners LLC 对 EWTX 的持仓演变

Parkman Healthcare Partners LLC 于 Q3 2023 首次披露 EWTX 持仓:473,312 股(约 US$2.7M)。 该持仓在 Q2 2026 达到峰值 577,036 股,市值约 US$23.4M。 在 13 次申报中,Parkman Healthcare Partners LLC 5 次增持、6 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 327,954 股、市值约 US$13.3M,环比减持 -249,082 股。。 持仓曾出现大幅变动:Q2 2025 增持约 52% (随后一个季度股价上涨 24%)、Q2 2026 增持约 79% (随后一个季度股价基本持平)、Q3 2026 减持约 43% (随后一个季度股价上涨 13%)。

逐季持仓明细

季度股数金额变化
Q3 2023 473.31K $2.71M 新进
Q4 2023 651.62K $7.13M 增持
Q1 2024 653.65K $11.92M 持有
Q2 2024 574.52K $10.35M 减持
Q3 2024 657.07K $17.54M 增持
Q4 2024 381.17K $10.18M 减持
Q1 2025 425.41K $9.36M 增持
Q2 2025 647.33K $8.49M 增持
Q3 2025 550.17K $8.92M 减持
Q4 2025 427.69K $10.61M 减持
Q1 2026 322.83K $10.17M 减持
Q2 2026 577.04K $23.44M 增持
Q3 2026 327.95K $13.31M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 EWTX 与 13F 数据

EWTX(EDGEWISE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 EWTX,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 EWTX 的基金

查看 EWTX 的全部基金持有人 →

常见问题

How long has Parkman Healthcare Partners LLC held EWTX?

Parkman Healthcare Partners LLC has disclosed EWTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Parkman Healthcare Partners LLC's current position in EWTX?

As of Q3 2026, Parkman Healthcare Partners LLC holds 327.95K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $13.31M, representing 1.20% of its reported portfolio and ranking #32.

Has Parkman Healthcare Partners LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in EWTX. The position peaked in Q2 2026 at 577.04K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.